The Ozempic rebound effect: what happens when you stop taking it and how to avoid it

The truth that no one wants to hear about Ozempic

Ozempic and Wegovy work. The data is clear: with 2.4 mg of semaglutide, the STEP clinical trials demonstrated weight losses of up to 17.3% of body weight in 68 weeks. With tirzepatide (Mounjaro), the results are even better. These are numbers that were previously unthinkable without surgery.

But there is a part of the story that is told less often: what happens when you stop taking the medication. And the answer, now supported by a meta-analysis published in The BMJ in January 2026 with data from more than 9,300 people and 37 studies, is blunt: the weight comes back, and it does so quickly.

In this article, we explain exactly what happens in the body when stopping a GLP-1 drug, why the rebound is so pronounced, who is at higher risk, and—above all—what you can do before, during, and after treatment to avoid it.

Because the rebound effect is not inevitable: it is preventable if you act in time.

The data: how much weight is regained and how quickly

The University of Oxford meta-analysis published in The BMJ in January 2026 analyzed what happens after stopping treatment with GLP-1 drugs. The results are the most comprehensive published to date:

• The average rate of weight regain after stopping semaglutide or tirzepatide is 9.9 kg in the first year.
• Participants were projected to regain all lost weight within an average of 1.5 years after stopping the medication.
• The speed of weight regain after stopping the drug is almost four times faster than after finishing a weight loss program based on diet and exercise.
• The average rate of regain is 0.4 kg per month after stopping treatment.

A specific analysis of the STEP 1 trial confirms this with precise data: patients who took semaglutide lost 17.3% of their weight during treatment. One year after stopping, they had regained 11.6%.

The actual net loss, after 68 weeks of treatment and 52 weeks without it, was only 5.6%.

In other words: 70% of people regain a significant portion of the weight, and many return to their starting point.

Furthermore, along with the weight, the health markers that had improved return: cholesterol, blood pressure, blood glucose, and cardiovascular risk. The rebound effect is not just aesthetic. It is a health problem.

Why the rebound effect occurs: the biology of the problem

The rebound effect with GLP-1s is not a failure of willpower. It is biology. Drugs like semaglutide work by acting on receptors in the brain and digestive system to suppress appetite and slow gastric emptying.

When you stop the medication, those receptors return to their baseline state: hunger returns, sometimes more strongly than before, while the body—accustomed to eating little—may have lost muscle mass, which slows down the metabolism.

There are three biological factors that explain the speed of the rebound:

• Return of appetite: without the pharmacological brake of the GLP-1, the hunger signals from the hypothalamus are fully reactivated, often with compensatory intensity.
• Loss of muscle mass during treatment: if an adequate protein intake was not maintained during weight loss, the basal metabolism is now slower, making it easier to regain fat on fewer calories.
• Absence of consolidated habits: the medication biologically suppresses appetite, which can lead to not developing conscious control skills. When that brake disappears, there is nothing to replace it.

Who is at higher risk of rebound

Not everyone who stops Ozempic or Wegovy regains the same amount of weight. Factors that increase the risk of rebound include:

• Having lost a lot of muscle during treatment (due to insufficient protein intake).
• Not having consolidated any structured eating habits during treatment.
• Stopping the medication abruptly, without a gradual reduction.
• Not having incorporated physical exercise, especially strength training, during treatment.
• Resuming pre-treatment eating patterns without a replacement structure.

In contrast, real-world studies show that those who restart other treatment, maintain dietary structure, or have developed solid habits during the drug's use experience significantly less weight regain than that observed in controlled clinical trials.

How to avoid the rebound effect: the three-pillar plan

The good news is that the rebound effect is not inevitable. But preventing it requires acting in advance—ideally, from the very first day of treatment, not when you are already stopping the medication.

Pillar 1 - Protein: protecting muscle during and after

The loss of muscle mass during GLP-1 treatment is one of the main accelerators of subsequent rebound. Muscle is the most metabolically active tissue: for every kilogram of muscle lost, the basal metabolism slows down, meaning the body needs fewer calories to maintain weight—and it is easier to gain fat.

Maintaining an intake of 1.2–1.5 g of protein per kg of ideal weight per day during treatment, and sustaining it in the maintenance phase, is the most effective measure to preserve muscle and protect the metabolism. Fitóniq products provide between 16 and 22 g of complete protein per ~200 kcal serving, with the necessary amino acid profile to activate muscle synthesis in each serving.

Pillar 2 - Dietary structure: the habit that lasts when the drug doesn't

This is the most ignored and most important pillar. The drug suppresses appetite, but it does not build habits. If you simply eat less during treatment without any structure, when appetite returns, there will be no reference system to modulate it.

Using the Fitóniq structure during treatment—2 servings a day in the active phase, 1 serving in the maintenance phase—builds exactly that system: portioned, predictable, nutritionally complete meals that can be easily maintained after the medication.

As the Fitóniq system itself points out, the goal is for the plan to resemble as closely as possible how you will eat after the diet, thus reducing the risk of rebound. Not by magic, but because you train the right habit while the medication is still helping.

Pillar 3 - Strength exercise: the metabolic insurance

Aerobic exercise is beneficial, but it is not enough to avoid rebound. Strength training—weights, resistance, functional exercises—is what preserves and rebuilds muscle mass, keeps the metabolism active, and creates an energy demand that the body sustains even at rest.

Incorporating it from the beginning of GLP-1 treatment, not at the end, is key: the habit of strength training is also consolidated during treatment and protects in the subsequent phase.

How to integrate Fitóniq into the transition: before, during, and after

The key is for Fitóniq to be the bridge between pharmacological treatment and life without medication.

One serving a day in the maintenance phase is a portioned, nutritionally complete meal of ~200 kcal that acts as an anchor: it maintains structure, provides protein and micronutrients, and prevents daily life from drifting toward the patterns that caused the excess weight.

You can start with the Fitóniq 2-week pack to establish structure from the start, or explore all products in the Fitóniq store to choose those that best adapt to your routine.

Frequently asked questions

Is the rebound effect inevitable when stopping Ozempic?

It is not inevitable, but it is very common if habits have not been consolidated during treatment. The Oxford meta-analysis published in The BMJ in 2026 shows that 70% of people regain weight, but those who maintain dietary structure and strength training experience significantly less regain.

How much weight is regained when stopping Wegovy or Ozempic?

According to the latest data, the average regain after stopping semaglutide is 9.9 kg in the first year. Without additional intervention, the projection is to regain all lost weight in approximately 1.5 years. The average rate of regain is 0.4 kg per month.

Why is weight regained so quickly when stopping semaglutide?

Because the drug pharmacologically suppresses appetite, and when removed, hunger returns—sometimes with more intensity. If muscle mass has also been lost during treatment, the metabolism is slower and the body accumulates fat more easily. The speed of the rebound is almost four times greater than after a conventional diet.

How to avoid the rebound effect when stopping Ozempic?

The three key pillars are: maintain an intake of 1.2–1.5 g of protein per kg of ideal weight per day, have a consolidated dietary structure (such as 1 daily serving of Fitóniq in maintenance), and practice strength exercise regularly. The sooner these habits are established—during treatment, not at the end—the better protected your weight loss will be.

Can Fitóniq help prevent weight regain after stopping Ozempic?

Yes. The European regulatory claim for meal replacements states that "replacing one of the main daily meals contributes to weight maintenance after weight loss."

A daily serving of Fitóniq in the post-treatment phase provides structure, complete protein, and more than 23 vitamins and minerals in ~200 kcal, acting as a habit anchor when the medication is no longer there. Discover the Fitóniq system and choose the pack that best adapts to your current moment.

This article is for informational purposes and does not replace medical advice. If you are being treated with GLP-1 medications, always consult your doctor or specialist before making changes to your diet or before stopping treatment.

Do you want to build the habits starting today that will prevent the rebound effect when you stop treatment? Discover the Fitóniq system and start with the 2-week pack.

Summary: what you need to remember

• 70% of people regain a significant portion of their weight after stopping Ozempic or Wegovy, and they do so at a speed almost four times greater than after a conventional diet.
• The average regain after stopping semaglutide or tirzepatide is 9.9 kg in the first year, with a projection of regaining all lost weight within 1.5 years.
• The rebound is not a failure of willpower: it is biology. The return of appetite, muscle loss, and the absence of habits explain it.
• The three pillars to avoid it are: sufficient protein, consolidated dietary structure, and strength exercise—all of these from the start of treatment, not the end.
• Fitóniq acts as a bridge: it builds structure during treatment and sustains it in the maintenance phase with 1 serving a day.